Welcome to hematology Tuesday, where we highlight notable pieces of content featured on Heme Today. Take a look at these important studies relevant to anemia, venous thromboembolism, sickle cell disease, and paroxysmal nocturnal hemoglobinuria.
Anemia Linked to Cognitive Dementia, Decline
Researchers, led by Jiao Wang, explored if anemia was associated with cognitive decline and risk of dementia, and if levels of inflammation affected any identified associations.
Lowering the Risk of VTE in Patients With Severe Blunt Trauma
Patients with severe blunt trauma who received low-molecular-weight heparin were less likely to experience venous thromboembolism than those who received factor Xa inhibitors.
Characterizing Infections in Pediatric Cases of Sickle Cell
Research showed the historical effect of pneumococcal conjugate vaccines on infections in children with sickle cell disease.
An Effective Treatment for Thromboembolic Events in Patients With PNH
A study that evaluated the overall survival and first occurrence of thromboembolic and major adverse vascular events in patients with paroxysmal nocturnal hemoglobinuria found eculizumab to be effective.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.